Teva Pharmaceutical Industries Limited
TEVA
Classifica tra le azioni
#13242
Teva Pharmaceutical Industries Limited operates as a prominent global... Teva Pharmaceutical Industries Limited operates as a prominent global pharmaceutical firm, involved in the research, development, manufacturing, marketing, and distribution of generic, specialized, and biopharmaceutical products throughout North America, Europe, and other international regions. The company's diverse portfolio encompasses sterile preparations, hormonal therapies, high-potency drugs, and cytotoxic substances, supplied in a wide array of dosage forms such as tablets, capsules, injectable solutions, inhalants, oral liquids, transdermal patches, topical ointments, and creams. Furthermore, Teva develops, produces, and sells active pharmaceutical ingredients (APIs). A significant portion of its research and product development is concentrated on the central nervous system, pain management, respiratory illnesses, and oncology. Leading products for the central nervous system include Copaxone, utilized for relapsing multiple sclerosis; AJOVY, an option for migraine prevention; and AUSTEDO, prescribed for tardive dyskinesia and chorea linked to Huntington's disease. Within the respiratory domain, addressing asthma and chronic obstructive pulmonary disease, Teva offers products like ProAir, QVAR, various Digihaler and RespiClick formulations, along with BRALTUS and CINQAIR/CINQAERO. Their oncology division features treatments such as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. The company also collaborates with MedinCell on the creation and commercialization of multiple extended-release injectable products, including a risperidone suspension designed for individuals with schizophrenia. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
Prezzo delle azioni
$41.51
Ultima sincronizzazione: 2026-10-16
Capitalizzazione di mercato
$483.77M
Variazione (1 giorno)
-0.85%
Variazione (1 anno)
107.47%
Paese
IL
Scambia Teva Pharmaceutical Industries Limited (TEVA)
Categoria
Healthcare
Capitalizzazione di mercato di Teva Pharmaceutical Industries Limited(TEVA)
Capitalizzazione di mercato: $483.77M
A partire dal October 2026, Teva Pharmaceutical Industries Limited ha una capitalizzazione di mercato pari a $483.77M. Questo rende Teva Pharmaceutical Industries Limited la 13242nd azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Teva Pharmaceutical Industries Limited dal 2010 al 2026
TEVA in paragone con la classifica dei più popolari stocks
